Last updated on February 2018

Non-interventional Study to Evaluate Long Term Safety Prescription Management Patterns of Esmya in a Long Term Setting

Brief description of study

This is a multi-centre, multinational, prospective, non-interventional study in females with a diagnosis of moderate to severe uterine fibroids, and for whom a treatment with Esmya in a long term manner is planned, and in subjects who were previously exposed to UPA in the long term Phase III studies. It is planned to enrol approximately 1,500 patients. Consecutive, eligible, patients will be invited to enrol from approximately 100-150 European Union (EU) clinical practice sites in approximately 15 countries. Patients will be followed for an observation period of 60 months (5 years) from treatment start. Investigators are to manage and treat patients according to their standard medical practice.

The specific objectives of the study are to assess the long term safety, including endometrial safety, of Esmya in standard medical practice and the prescription patterns of Esmya in standard medical practice.

The exploratory objective is to assess patients' quality of life in a long-term treatment setting.

Clinical Study Identifier: NCT02748460

Find a site near you

Start Over

Arrowe Park Hospital

Wirral, United Kingdom
  Connect »

G-Centrum Olomouc S.R.O.

Olomouc, Czech Republic
  Connect »

Leicester General Hospital

Leicester, United Kingdom
  Connect »

Uherskohradistska Nemocnice A.S

Uherske Hradiste, Czech Republic
  Connect »

Private practice

Brno, Czech Republic
  Connect »


Riga, Latvia
  Connect »

Gynekologicka ordinace

Ceske Budejovice, Czech Republic
  Connect »

Royal Bolton Hospital

Bolton, United Kingdom
  Connect »


Frankfurt Am Main, Germany
  Connect »

Praxis am Markt

Dortmund, Germany
  Connect »

London North West healthcare trust

Harrow, Middlesex, United Kingdom
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.